Cargando…
Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate
BACKGROUND: Dengue is a rapidly spreading mosquito borne tropical viral disease affecting hundreds of millions of people across the globe annually. The dengue virus (DENV) includes four genetically distinct serotypes that cause serious life-threatening infections, including dengue hemorrhagic fever/...
Autores principales: | Bal, Jyotiranjan, Jung, Hee-Young, Nguyen, Luong Ngoc, Park, Jisang, Jang, Yong-Suk, Kim, Dae-Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138890/ https://www.ncbi.nlm.nih.gov/pubmed/30217208 http://dx.doi.org/10.1186/s12934-018-0994-8 |
Ejemplares similares
-
Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
por: Bal, Jyotiranjan, et al.
Publicado: (2018) -
Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination
por: Nantachit, Nattika, et al.
Publicado: (2016) -
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences
por: Sankaradoss, Arun, et al.
Publicado: (2022) -
Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014) -
Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae
por: So, Kum-Kang, et al.
Publicado: (2021)